Navigation Links
Phosphagenics to Commence Phase 1b Transdermal Insulin Clinical,Trial in Second Quarter

MELBOURNE, Australia, May 03, 2007 /PRNewswire-FirstCall/ -- Phosphagenics Limited (AIM: PSG) announced today that the Company intends to initiate a Phase 1b clinical trial to demonstrate the efficacy and safety of the improved formulation of its transdermal insulin product, TPM-02/Insulin, containing long-acting insulin. The trial is expected to commence in the second quarter of 2007.

TPM-02/Insulin gel is being developed as a novel "needle-free" way of administering insulin to patients with diabetes. Following the successful completion of a Phase 1a study utilizing short-acting insulin, this trial will assess an optimized formulation of long-acting insulin. Recent advancements in Phosphagenics' patented TPM-02 delivery system have enabled the formulation of long-acting insulin; which is significantly less expensive than short- acting insulin, provides appropriate levels of insulin in humans and is commercially attractive.

"In August of 2006, our Phase 1a study demonstrated that a single application of TPM-02/Insulin gel rapidly delivered insulin across the skin and into the bloodstream without any adverse reactions," said Dr. Esra Ogru, Executive Vice President at Phosphagenics. "Additionally, it significantly lowered blood glucose, insulin and c-peptide levels."

"The Phase 1b study is intended to provide additional supporting data for an Investigational New Drug application to the U.S. Food and Drug Administration," continued Dr. Ogru. "The trial will be conducted by CMAX at the Royal Adelaide Hospital, South Australia, will include up to 45 healthy volunteers and is expected to lead directly into the start of a large multi- site Phase 2 trial that is likely to include up to several hundred patients."

"This is an important step for the development and commercialization of TPM-02/Insulin," said Harry Rosen, President and CEO of Phosphagenics. "This technology has the potential to p
'"/>




Page: 1 2

Related medicine technology :

1. Phosphagenics Announces Positive Proof of Concept Results from Studies Utilizing Companys Dermal Drug Delivery Technology
2. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
3. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
Post Your Comments:
(Date:5/28/2015)... -- IRIDEX Corporation (NASDAQ: IRIX ) today announced that Chief ... is scheduled to present at the LD Micro Invitational ... Los Angeles . A live ... Event Calendar of the Investors section of IRIDEX,s website at ... available shortly after the conclusion of the presentation and will ...
(Date:5/28/2015)... NEW YORK , May 28, 2015 /PRNewswire/ ... morcellators ( http://www.morcellatorlawsuit2015.com )  in hysterectomies and myomectomies (procedures ... report indicates that the FBI is investigating Johnson ... the largest manufacturer of the devices. According to ... on May 27 th , the FBI is ...
(Date:5/28/2015)... , May 28, 2015 ... announced the addition of the "United States ... report to their offering.      (Logo: ... adhesives in the United States ... 2020 Medical device manufacturers across ...
Breaking Medicine Technology:Power Morcellator Attorneys at Bernstein Liebhard LLP Comment on Report That FBI Is Investigating Ethicon Morcellators 2Power Morcellator Attorneys at Bernstein Liebhard LLP Comment on Report That FBI Is Investigating Ethicon Morcellators 3United States Medical Adhesives Market Forecast and Opportunities, 2020 - New Medical Innovations with 3M, Henkel Adhesive Research, Ethicon and Cyberbond Dominating 2United States Medical Adhesives Market Forecast and Opportunities, 2020 - New Medical Innovations with 3M, Henkel Adhesive Research, Ethicon and Cyberbond Dominating 3
... VALLEY, Pa., Dec. 14, 2011 /PRNewswire-iReach/ -- ... by introducing a collection of EZ Shot 2 single-use ... needles offer excellent puncture capability along with an adjustable ... targeted site. Available in a complete selection of sizes ...
... 14, 2011  The National Association of Drug ... that facilitates cooperation between law enforcement, healthcare ... in the prevention and investigation of drug ... National Precursor Log Exchange (NPLEx) in Indiana ...
Cached Medicine Technology:Olympus Broadens Portfolio With a Suite of New Single-Use Aspiration Needles 2Indiana Stop-Sale System Shows Effectiveness of Real-Time, Blocking Technology in the Fight Against Illegal Sales of Pseudoephedrine 2
(Date:5/29/2015)... San Diego, California (PRWEB) May 29, 2015 ... Common Core” and have joined the national effort to teach ... Many parents in the U.S. have been “sickened” by the ... country. However, love it or hate it, Common Core is ... the District of Columbia. Parents are now seeking ways ...
(Date:5/29/2015)... May 29, 2015 The print component ... a circulation of approximately 250,000 and an estimated readership ... a vast social media strategy, and across a network ... the digital version of the campaign, click here. ... print publication. Inside, the actress, model and producer details ...
(Date:5/29/2015)... Ill (PRWEB) May 29, 2015 OncLive ... , a dozen medical pioneers recognized by a panel ... the course of cancer treatment. Honorees will be introduced ... Cancer Care™ Award Ceremony, held 8:30-11:00 p.m. CDT at ... The 2015 honorees are being recognized for groundbreaking accomplishments, ...
(Date:5/29/2015)... Oaksterdam University, the first cannabis college in America, will return to ... highly demanded Basic and Advanced Classic Seminars on ... pm each day. Certification is available upon completion of the seminars ... June 14 from 12:00 pm to 6:00 pm. Both the seminars ... & Casino in downtown Las Vegas. , Seminar topics ...
(Date:5/29/2015)... (PRWEB) May 29, 2015 Designed with ... teamed up to create an all new, exclusive line ... a formulated with the latest and greatest, high impact, ... proven to be effective. The 24/7 Series can be ... cross-fitters and even the casual fitness enthusiasts. There are ...
Breaking Medicine News(10 mins):Health News:Doctors Discover a Cure for the Common Core 2Health News:OncLive's 2015 Giants of Cancer Care™ Awards Announced Today 2Health News:OncLive's 2015 Giants of Cancer Care™ Awards Announced Today 3Health News:OncLive's 2015 Giants of Cancer Care™ Awards Announced Today 4Health News:Oaksterdam University to Host Educational Cannabis Seminars and Job Fair in Las Vegas June 12 to 15; Training For Those Wanting To Work in Legal Cannabis Industry 2Health News:Oaksterdam University to Host Educational Cannabis Seminars and Job Fair in Las Vegas June 12 to 15; Training For Those Wanting To Work in Legal Cannabis Industry 3Health News:BPI Sports and Bodybuilding.com Partner Up to Bring an Innovative New Line of Supplements 2Health News:BPI Sports and Bodybuilding.com Partner Up to Bring an Innovative New Line of Supplements 3
... ... ROI , ... NY and Piscataway NJ (PRWEB) June 4, 2010 -- UniteU Technologies, Inc., a leading ... solutions for online stores, are announcing the availability of Filtered Navigation Search Express (FNS ...
... first time, scientists have discovered a possible biological culprit ... type of estrogen called estradiol. The groundbreaking pilot ... of one,s genes on eating disorder symptoms was much ... than pubertal girls with lower levels of estradiol. The ...
... researchers say , FRIDAY, June 4 (HealthDay News) ... Wii Sports -- may help overweight seniors become more ... Although not an improvement on real-life gaming and sports ... offer a good alternative for those older individuals for ...
... ... recently selected to receive the AAOMS (American Association of Oral & Maxillofacial Surgeons) Humanitarian Award ... ... been selected to receive the AAOMS (American Association of Oral & Maxillofacial Surgeons) Humanitarian Award ...
... ... virtualisation software SoftXpand, as the exclusive distributor for supplying its award-winning multi-user solution to ... ... been appointed by Miniframe, supplier of innovative desktop virtualisation software SoftXpand, as the exclusive ...
... ... full, four year accreditation by the Board of Vocational Nursing and Psychiatric Technicians (BVNPT). ... Modesto, CA ... that its Modesto and Fresno Campuses, Vocational Nursing Programs have been recently awarded a ...
Cached Medicine News:Health News:UniteU and Celebros Launch Dynamic Cross-Sell and New Version of Filtered Navigation Search 2Health News:UniteU and Celebros Launch Dynamic Cross-Sell and New Version of Filtered Navigation Search 3Health News:MSU researchers discover potential genetic factor in eating disorders 2Health News:Wii Games Can Get Seniors Moving 2Health News:Dr. Randolph C. Robinson Recently Awarded AAOMS (American Association of Oral & Maxillofacial Surgeons) Humanitarian Award 2Health News:Dr. Randolph C. Robinson Recently Awarded AAOMS (American Association of Oral & Maxillofacial Surgeons) Humanitarian Award 3Health News:London Web Expands Green IT with SoftXpand Desktop Virtualisation Solution 2Health News:London Web Expands Green IT with SoftXpand Desktop Virtualisation Solution 3
Optipress II Automated Blood Component Extractor for the standardized separation of whole blood into high purity individual components...
... Stepper, a lightweight, easy-to-use repeater ... up to 45 times in ... Stepper handle is adapted for ... a dispensing volume range from ...
... The Repeater Plus, a handheld manual dispenser, ... time on long series pipetting. Its increased ... support for research tasks, and its smooth ... repetitive work. The nine Combitips allow a ...
... of its kind, the noncontact EnSite ... cardiac electrical information, translating it into ... electrodes, this unique tool simplifies ablation ... points of electrical data in a ...
Medicine Products: